BUG-V (aka: BIPMF) BIOPHAGE PHARMA INC JUL 07 2006 06:13 AM Signs an MOU with Two U.S. Companies
Indus & ISC to develop & manufacture a new generation of PDS(R) biosensors
Biophage Pharma Inc. ("Biophage") announces that it has signed a memorandum of understanding with two U.S. companies, Indus Instruments, Houston, Texas ("Indus"), and International Science Consulting, LLC, West Haven, Connecticut, ("ISC"), for the development and manufacturing of the a new generation of PDS(R) biosensors.
Under this MOU, Indus and ISC will develop for Biophage proprietary equipment for the detection of live bacterial pathogens and their toxins. As compensation, Indus and ISC will receive US$50,000 and 3,800,000 non-transferable warrants, each such warrant entitling the holder thereof to purchase one common share of the capital of Biophage at any time, for a period of two years after the date of its grant. Out of the 3,800,000 abovementioned warrants, 2,800,000 will be exercisable at a price of CAN$0.12 and 1,000,000 will be exercisable at a price of CAN$0.30. The parties have agreed to enter into a more detailed development agreement. "Over the coming weeks and months, I look forward to sharing with our stockholders the new technologies and commercial markets we will be entering with our new generation of biosensor technologies," commented Dr Mandeville, President and CEO of Biophage Pharma Inc. "We are very excited with the opportunity to partner with Biophage Pharma and help them acquire in an opportune time, a competitive PDS(R) Biosensor units that will be reasonably priced and will offer a higher level of performance over conventional testing standards," stated Dr Sridhar Madala, President of Indus Instruments.
About Biophage Pharma Inc.
Biophage Pharma is a high potential Canadian biotechnology company focused on the development of novel phage-based technologies for the detection and management of live pathogens and cell cytotoxicity testing. Founded in 1995, Biophage Pharma has completed the development of its first prototype PDS (R) Biosensor and is entering in the pre-commercialization stage. The Corporation has also an important profit center that provides services in Immunogenicity and Immunotoxicity, in Beryllium sensitivity testing and MELISA (R) for the detection of allergy to more than 20 different metals and a very large number of allergens including antibiotics (penicillin, Gentamycin) and pollens. (www.biophagepharma.com; www.immunotoxlabs.com).
About Indus Instruments
Indus Instruments is a Texas based company specialized in the design, development, and manufacture of electronic devices and computer systems for the medical, industrial, and scientific instrumentation markets. Since 1992 Indus has helped numerous clients in a wide variety of fields turn their ideas into products. Indus offers services ranging from design reviews, R&D proposal assistance, prototype development, patent applications to manufacturing assistance. (www.indusintruments.com).
About International Science Consulting, LLC
International Science Consulting, LLC is a Connecticut based scientific and general management consulting firm whose mission is to help early stage companies create and sustain a competitive advantage. ISC uses its knowledge and resource capabilities to assist products, systems and technologies development. ISC provides focused, practical and high value-added scientific, management and business development services to individuals and corporations.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
Capitalization Report for Biophage Pharma Inc Shares Issued: 32221312 Shares Escrow: 7090832
TSX Venture closing price for Biophage Pharma I Date: 2006/07/06 Closing Price: 0.110
TEL: (514) 496-1488 Biophage Pharma Inc. Rosemonde Mandeville M.B. Ch.B. PhD President and Chief Executive Officer EMAIL: rosemonde.mandeville@biophagepharma.com
TEL: (514) 939-3989 Renmark Financial Communications Inc. Investor Relations: Christine Stewart EMAIL: cstewart@renmarkfinancial.com Christina Lalli EMAIL: clalli@renmarkfinancial.com INET : www.renmarkfinancial.com
TEL: (281) 286-1130 Indus Instruments: Sridhar Madala PhD President EMAIL: Sridhar@indusinstruments.com
. |